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ORIGINAL ARTICLE
Background/Aims: Organophosphate poisoning has a high mortality rate. Recently, differences among
organophosphorus insecticides in human self-poisoning were reported. This study investigated the prognostic
risk factors and the mortality of different organophosphates following acute organophosphate poisoning.
Methods: This retrospective study included 68 patients with acute organophosphate poisoning. We investigated
patient survival according to initial parameters, including the initial Acute Physiology and Chronic Health Evaluation
(APACHE) II score, serum cholinesterase level, and hemoperfusion and evaluated the mortality according to
organophosphate types. 
Results: Thirteen of the 68 patients died. The agents responsible for mortality were different. The APACHE II
score was a significant predictor of mortality (odds ratio [OR], 1.194; p<0.01; 95% confidence interval [CI], 1.089
to 1.309) and respiratory failure (OR, 1.273; p<0.01; 95% CI, 1.122 to 1.444). The mortality was 0% for dichlorvos,
malathion, chlorpyrifos and profenofos. However, other organophosphates showed different mortality (16.7% for
O-ethyl-O-4-nitrophenyl phenylphosphonothioate, 25% for phenthoate, 37.5% for phosphamidon, 50% for
methidathion). The usefulness of hemoperfusion appears to be limited. 
Conclusions: The initial APACHE II score is a useful prognostic indicator, and different organophosphates have
different mortality. (Korean J Intern Med 2009;24:362-367)
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INTRODUCTION
Organophosphates (OP) inhibit acetylcholinesterase
and cause excessive acetylcholine accumulation, which
affects muscarinic and nicotinic receptors at synapses
within the peripheral and central nervous systems [1]. OP
poisoning causes neurotoxic sequela and has a high
mortality rate [2-4].
The World Health Organization (WHO) estimates
that the incidence of pesticide poisoning in developing
countries has doubled during the past 10 years [5]. In
Korea, the mortality due to poisoning has increased rapidly
since 1998 [6]. Herbicides and pesticides constituted
the largest proportion of deaths due to poisoning of all
causes, although OP were not evaluated specifically [6].
Combined atropine and pralidoxime therapy is the
cornerstone of OP poisoning treatment. Extracorporeal
elimination may be a useful adjunctive strategy. However,
the use of hemoperfusion in the management of severe OP
poisoning remains controversial [7-10].
Recently, a difference among OP insecticides in human
self-poisoning was reported. Moreover, the toxicity differed
in humans and animals. These finding suggest that each
OP has a different toxicity, although textbooks and articles
have traditionally considered acute OP poisoning as a
homogenous entity.
This study determined the predictors of a poor outcome
in patients with acute OP poisoning and differences of
toxicity according to OP type. Kang EJ, et al. Acute organophosphate poisoning    363
METHODS
Study population
This retrospective study examined the comprehensive
medical, nursing, and intensive care records of 68 patients
admitted to the Institute of Pesticide Poisoning at
Soonchunhyang University Cheonan Hospital, Cheonan,
Korea, for acute OP poisoning between January 2000 and
December 2006. The Investigational Review Board at
Soonchunhyang Cheonan Hospital approved this study.
Initial diagnoses were established in all cases based on
cholinergic clinical features, the odor of OP in the gastric
contents, history, and other circumstantial evidence, such
as the poison or a label of an OP-containing product found
by relatives. All patients were given the classic treatment
for OP poisoning: gastric lavage, whole body surface
washing, activated charcoal administration (1 g/kg by
nasogastric tube), intravenous atropine and pralidoxime,
and supportive measures such as mechanical ventilation
(if necessary). Hemoperfusion (Absorba 300; Gambro,
Hechingen, Germany) was performed for 3.5 hours when
patients developed respiratory failure or mental changes.
Complete blood cell counts, measures of liver and renal
function, and arterial blood gases were obtained. The Acute
Physiology and Chronic Health Evaluation (APACHE) II
scores of all patients were determined. The 68 subjects
were allocated to two groups: a respiratory failure group
(the RF group) requiring mechanical ventilation, and a
non-respiratory failure group (the non-RF group).
Table 1. Characteristics of patients with acute
organophosphate poisoning
Characteristic Value
(n=68)
Age, yr 54.5 (16-91)*
Men 38 (56)
Agent
Dichlorvos 21 (30.9)
EPN 12 (17.6)
Phosphamidon 8 (11.8)
Phenthoate 4 (5.9)
Malathion 3 (4.4)
Methidathion 2 (2.9)
Profenofos 2 (2.9)
Unknown 15 (22.1)
Estimated amount ingested, mL 60 (5-500)*
Time interval between exposure  3 (0.25-148)*
and hospital arrival, hr
Serum cholinesterase, IU/L 209 (7-2707)*
APACHE II score 10.72±10.97†
Hemoperfusion 40 (58.8)
Death 13 (19.1)
Ventilation required 35 (51.5)
Value are number (%) except where indicated otherwise.
EPN,O-ethyl-O-4-nitrophenyl phenylphosphonothioate;
APACHE, Acute Physiology and Chronic Health Evaluation.
*Median (range).
†Mean±SD.
Table 2. Comparison of the initial parameters in patients with or without respiratory failure (RF)
RF Non-RF p value
APACHE II score 16.6±10.4 4.5±4.3 0.00
Serum cholinesterase, IU/L 222.0±333.6 3056.4±2584.1 0.00
White blood cell, mm
3 15153.1±6144.7 12293.0±5231.6 0.04
Lactate dehydrogenase, IU/L 648.1±391.3 470.3±97.1 0.01
Glutamic-oxaloacetic transaminase, IU/L 86.4±130.6 38.4±30.7 0.04
Glutamic-pyruvic transaminase, IU/L 54.8±102.0 26.6±14.4 0.11
Amylase, IU/L 367.4±458.7 299.3±355.6 0.50
Lipase, IU/L 120.2±197.2 139.7±287.9 0.75
pH 7.3±0.2 7.4±0.1 0.04
PCO2, mmHg 37.1±18.1 35.3±6.9 0.58
PaO2, mmHg 85.8±30.6 87.7±29.0 0.79
HCO3, mmol/L 17.1±5.6 20.4±4.8 0.01
Values are mean±SD.
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Statistical analysis
Data are presented as the mean±SD. Probability values
of p<0.05 were considered significant, and all statistical
analyses were performed using SPSS version 12.0 (SPSS
Inc., Chicago, IL, USA). Continuous variables were analyzed
using the Student’s t-test, and categorical variables were
analyzed using the chi-square test. Binary logistic regression
or multiple logistic regression analysis was used to identify
factors associated with a poor outcome.
RESULTS
The general characteristics of the 68 study subjects,
who all had acute OP poisoning at presentation, are sum-
marized in Table 1. The mean amount of ingested OP was
60 mL (range, 5 to 500) and the agents responsible for
poisoning were dichlorvos (n=21), O-ethyl-O-4-nitrophenyl
phenylphosphonothioate (EPN, n=12), phosphamidon
(n=8), phenthoate (n=4), malathion (n=3), methidathion
(n=2), profenofos (n=2), chlorpyrifos (n=1), and an
unidentified OP (n=15).
The RF group included 35 of the 68 patients. The mean
duration of mechanical ventilation was 9.5±8.3 days. A
tracheostomy was performed in 17 of these 35 patients.
Table 2 shows the comparison of initial parameters in the
RF and non-RF groups. The APACHE II score, white
blood cell count, and lactate dehydrogenase and aspartate
aminotransferase levels were higher in the RF group, and
the serum cholinesterase and bicarbonate levels were
lower than the non-RF group. No significant difference in
the arterial oxygen partial pressures at presentation was
observed between the two groups. The APACHE II score
was a significant predictor of respiratory failure (odds ratio
[OR], 1.273; p<0.01; 95% confidence interval [CI], 1.122 to
Table 3. Multiple logistic regression analysis of the initial parameters associated with respiratory failure
Variable Odds ratio 95% Confidence interval p value
Age 0.932 0.855-1.015 0.106
Estimated amount ingested 0.985 0.963-1.007 0.186
Hemoperfusion 1.405 0.108-18.313 0.795
Serum cholinesterase, IU/L 0.995 0.990-0.999 0.019
APACHE II score 1.663 1.019-2.715 0.042
APACHE, Acute Physiology and Chronic Health Evaluation.
Figure 2. The association between serum cholinesterase and
the Acute Physiology and Chronic Health Evaluation (APACHE) II.
A negative correlation between the APACHE II score and serum
cholinesterase level was significant.
Figure 1. The comparison of clinical outcome in patients with
or without hemoperfusion treatment. The Acute Physiology and
Chronic Health Evaluation (APACHE) II scores were higher in
patients with hemoperfusion treatment, but hemoperfusion
treatment did not affect mortality.Kang EJ, et al. Acute organophosphate poisoning    365
1.444). In addition, the APACHE II score was an important
predictor of RF in the multiple logistic regression analysis
(Table 3).
Information on the patients according to hemoperfusion
treatment is presented in Fig. 1. The APACHE II scores
were higher in patients with hemoperfusion treatment,
but hemoperfusion treatment did not affect mortality.
Regardless of hemoperfusion treatment, the APACHE II
scores were higher and cholinesterase levels were lower in
those who died.
Thirteen of the 68 patients died. The clinical parameters
are summarized in Table 4. The serum cholinesterase
levels were lower in those who died. Twelve of the 35 RF
group patients and only one of the non-RF patients died.
Therefore, the need for mechanical ventilation was a
significant predictor of a poor outcome (OR, 16.70; p<0.01;
95% CI, 2.03 to 137.60).
In addition, the APACHE II score was a significant
predictor of mortality (OR, 1.194; p<0.01; 95% CI, 1.089
to 1.309). An APACHE II score <10 was a significant
predictor of mortality (OR, 16.11; p<0.01; 95% CI, 3.17 to
81.73); a serum cholinesterase <1,000 IU/L was
significantly associated with a poor outcome (OR, 0.676;
p<0.05; 95% CI, 0.54 to 0.845).
Pearson’s correlation analysis revealed a significant
negative correlation between the APACHE II score and
serum cholinesterase level (r=0.415, p<0.01, Fig. 2).
An age over 60 years was also a significantly predictor
of a poor outcome (OR, 6.852; p<0.01; 95% CI, 1.677 to
28.003). Hemoperfusion treatment was not related to a
better outcome, although the patients who underwent
hemoperfusion were in poorer condition (e.g., their
APACHE II scores were higher).
Regarding the agents responsible, the death rate was
0% (0 of 21 of cases) for dichlorvos, 16.7% (2/12) for EPN,
37.5% (3/8) for phosphamidon, 25% (1/4) for phenthoate,
0% (0/3) for malathion, 50% (1/2) for methidathion, 0%
(0/2) for profenofos, 0% (0/1) for chlorpyrifos, and 40%
(6/15) for unidentified OP.
DISCUSSION
OP poisoning is a serious clinical entity and causes
considerable mortality and polyneuropathy in survivors
that is not always completely reversible. The estimated
mortality following OP ingestion ranges from 20 to 50%
[3,10-12].
In this study, the total mortality was 19% (13 deaths in
68 patients), and 12 of these deaths occurred in the 35
patients with respiratory failure. In our study, age,
amount ingested, APACHE II score, initial cholinesterase
level, and respiratory failure requiring mechanical
ventilation were significantly associated with a poor
outcome. The usefulness of the serum cholinesterase
level in this context remains controversial [13,14]. In our
patients, the cholinesterase level was correlated with
the APACHE II score (Fig. 2), but this findings casts
Table 4. Comparison of the initial parameters between survivors and non-survivors
Survivors Non-survivors p value
Age, yr 50.6±17.1 65.9±12.6 0.03
Estimated amount ingested, mL 90.0±105.5 215.4±159.3 0.02
APACHE II score 7.8±7.1 23.5±11.1 <0.01
Serum cholinesterase, IU/L 1848.2±2389.8 110.7±167.9 <0.01
White blood cells, µL 13031.5±5158.7 16869.2±7673.7 0.11
Lactate dehydrogenase, IU/L 509.5±135.1 782.9±596.7 0.13
Aspartate aminotransferase, IU/L 43.9±35.6 144.3±198.8 0.10
Alanine aminotransferase , IU/L 30.4±18.5 86.3±163.9 0.24
Amylase, IU/L 358.9±451.8 234.5±116.6 0.08
Lipase, IU/L 147.1±267.4 53.4±38.6 0.03
pH 7.4± 0.1 7.2±0.3 0.15
PaCO2, mmHg 34.9±12.4 42.0±17.8 0.19
PaO2, mmHg 86.6±25.8 87.2±43.6 0.96
HCO3, mmol/L 19.0±5.1 17.3±6.8 0.40
Values are mean±SD.
APACHE, Acute Physiology and Chronic Health Evaluation II score.366 The Korean Journal of Internal Medicine Vol. 24, No. 4, December 2009
doubt on the usefulness of the cholinesterase level in
patients with a low APACHE II score. The APACHE II
score is a reliable general index that is useful for evalu-
ating a wide spectrum of patients in intensive care units
[15], and essentially shows that the degree of physiological
derangement is closely correlated with outcome in critically
ill patients. In a previous study, an APACHE II score >26
was a poor prognostic indicator in cases of OP poisoning
[16], and the both APACHE II score and Glasgow coma
scale predicted outcome [17,18]. In our study, the APACHE
II score was correlated with respiratory failure and
outcome. In particular, an APACHE II score >10 predicted
a poor outcome.
Extracorporeal methods of blood purification have
recently been recommended as a therapeutic approach
to OP poisoning because of their ability to remove
xenobiotics from blood, particularly hemoperfusion
systems involving activated charcoal or resins [9,19,20].
However, the therapeutic benefits of this approach have
not been substantiated by other investigators, and this
has been explained by the large volume of distribution.
The use of hemoperfusion for managing severe OP
poisoning is also controversial [7,9]. In a study of 52 OP-
poisoned patients, Altinop et al. [7] reported that hemo-
perfusion was useful in severe cases. By contrast, in our
study, hemoperfusion was ineffective for improving
survival, although it should be emphasized that the
patients who were hemoperfused had high APACHE II
scores, which makes it difficult to evaluate the effect of
hemoperfusion. Randomized controlled studies are
required to investigate the effect of hemoperfusion on
survival in patients with severe OP poisoning.
Various types of OP were included in this study. No
death occurred in 21 patients with dichlorvos poisoning,
although the mean patient APACHE II score was 5.52±
5.01. By contrast, 2 of 12 EPN cases, 3 of 8 phosphamidon
cases, and 1 of 4 phenthoate cases died. This suggests
that different OP have different toxicities. Eddlestone
reported differences in the toxicity of OP [21]. In addition,
the human toxicity differed from the animal toxicity
suggested by WHO methods based on the toxicity in rats
after oral dosing. That report suggested that each OP be
considered as an individual poison. Our findings were
consistent with that opinion.
We conclude that the initial APACHE II score is a useful
prognostic indicator in cases of OP poisoning. Each OP
might have a different toxicity. The management protocol
for each OP in humans needs further study. Moreover, our
results suggest that hemoperfusion is of limited benefit
in cases of severe OP poisoning. Further randomized
controlled studies of the beneficial effects of hemoperfusion
on patient survival are required.
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